• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Sunday, July 5, 2026
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Invictus Oncology A Biopharma Firm Acquires Funding From Tata

by Nitin Konde
February 8, 2016
in Business, News
Reading Time: 2 mins read
0
Invictus Oncology A Biopharma Firm Acquires Funding From Tata
TwitterWhatsappLinkedin

 

You might also like

The AI Industrial Drone Wisconsin Homeowners Sue Microsoft Over Data Center Noise

UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies’ IPOs

Invictus

8 February, 2016, Delhi: Ratan Tata has been aggressively investing startups recently. Making its sixth investment in the row this year, Ratan Tata, chairman emeritus of Tata Sons has invested an undisclosed amount in Invictus Oncology Pvt. Ltd. in its series A Funding.

With this Ratan Tata had made his sixth investment in startups this year. Earlier he had invested in animal lovers’ portal Dogspot, coupons site CashKaro and baby products e-commerce site FirstCry.com, among others. He has been very aggressively investing in the startups and was among the most active angel investor last year.

Founded by R.A Mashelkar, former Director General, Council of Scientific and Industrial Research, and Shiladitya Sengupta, Harvard Medical School, It is a cancer therapeutics venture.

According to the WHO (World Health Organisation), 70 per cent of all cancer deaths occur in developing countries. Globally, India ranks third in terms of total new cancer cases occurring yearly. Cancer is also the second most common disease with about 0.3 million deaths per year. To this end, access to efficacious and affordable cancer drugs is still limited or nonexistent for most cancer patients in developing countries and thus, a diagnosis of cancer is synonymous to a death sentence.

Company aims to fight cancer by discovering novel, anti cancer therapeutics right here in India. It believes in the ‘treatment for all’ concept and aim to reach out to cancer patients from all sectors of society with innovative therapies at lower costs. This can be achieved if drug discovery and development takes place in India with the same benchmarks used in developed countries. Invictus Oncology strives to accelerate this by collaborative partnerships with organizations, hospitals and other key stakeholders.

Read: See more news articles on Ratan Tata’s investment in startups

Ratan Tata invests in B2B Marketplace Moglix

Ratan Tata Invests In India’s Largest Pet’s Portal DogSpot.in

Ratan Tata Shows Trust In Teabox

Tracxn Raises An Undisclosed Amount Of Funding From Ratan Tata

Ratan Tata Makes His Fourth Investment In Startup

Tags: CashkaroDogspotFirstCry.comHarvard Medical SchoolInvictus Oncology Pvt. Ltd.Ratan TataShiladitya SenguptaWHO
Tweet54SendShare15
Previous Post

Ratan Tata invests in B2B Marketplace Moglix

Next Post

Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Nitin Konde

Recommended For You

The AI Industrial Drone Wisconsin Homeowners Sue Microsoft Over Data Center Noise

by Anochie Esther
July 5, 2026
0
data center noise complaints

The massive, cross-country expansion of artificial intelligence infrastructure is fast colliding with local community standards and basic residential property rights. Across the United States, tech titans are racing...

Read more

UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

by Ishaan Negi
July 5, 2026
0
UK Culture Secretary Lisa Nandy Quits X, Calls Platform a Threat to Healthy Public Debate

The debate over social media's role in modern society has taken another dramatic turn. UK Culture Secretary Lisa Nandy has announced that she is leaving X (formerly Twitter),...

Read more

OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies’ IPOs

by Rounak Majumdar
July 4, 2026
0
OpenAI Plans Sharp AI Price Cuts As Anthropic Rivalry Heats Up Ahead Of Both Companies' IPOs

The AI industry's two most famous rivals are on the verge of a pricing war that could change the sector's economics, just as both companies prepare to go...

Read more
Next Post
Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at info@techstory.in

Advertise With Us

Reach out at - info@techstory.in

Aviator Game India 2026

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple Artificial Intelligence bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News OpenAI samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2025 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2025 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?